# Revelation Biosciences, Inc.: Form 8-K, filed Aug 6, 2026

- Company: [Revelation Biosciences, Inc.](/companies/revb.md) (CIK 1810560)
- Form: 8-K
- Filed: 2026-08-06
- Accepted by EDGAR: Aug 6, 2026, 16:19 ET
- Period: 2026-08-06
- Accession: 0001193125-26-338097
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810560/000119312526338097/revb-20260806.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810560/000119312526338097/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810560/000119312526338097/revb-20260806.htm

Filed Aug 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-338097. Last ingested by Listed: Nov 5, 2026, 21:10 ET. No prices; not investment advice.